Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening – Intensive Care Medicine Commentary on Twitter RV failure in moderate-to-severe #COVID19 #ARDS➡️strong predictor of mortality➡️significant worsening of PaO2/FiO2, PaCO2 & ventilatory ratio (⬆️ pulm vasoconstriction) & ⬆️ driving P could contribute#POCUS mandatory especially […]
The post Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening. appeared first on Links Medicus.
Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy – JAMA Network Open
The post Cohort Study: Thromboembolic risk in patients with pneumonia and new-onset atrial fibrillation not receiving anticoagulation therapy. appeared first on Links Medicus.
Efficacy of Physiotherapy Interventions on Weaning in Mechanically Ventilated Critically Ill Patients: A Systematic Review and Meta-Analysis – Frontiers in Medicine
The post M-A: Efficacy of physiotherapy interventions on weaning in mechanically ventilated critically ill patients. appeared first on Links Medicus.
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study – The BMJ Editorial: Are vaccines a potential treatment for long covid? – The BMJ News Release: Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms – BMJ Newsroom Commentary on Twitter LONG COVID: Number of well controlled studies […]
The post Cohort Study: Trajectory of long covid symptoms after covid-19 vaccination. appeared first on Links Medicus.
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 – New England Journal of Medicine Editorial: Audio Interview: Waning Immunity against Covid-19 Commentary on Twitter Protection against SARS-CoV-2 waned over time in both vaccinated and previously infected persons; an additional vaccine dose restored protection, find investigators from Israel. https://t.co/617uBmWu8l pic.twitter.com/yiDnBbCuQ5 — NEJM (@NEJM) […]
The post Cohort Study: Protection and waning of natural and hybrid immunity to SARS-CoV-2. appeared first on Links Medicus.
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron – New England Journal of Medicine
The post Test-negative, case–control study: effectiveness of homologous and heterologous Covid-19 boosters against Omicron. appeared first on Links Medicus.
Commentary: Long COVID risk falls only slightly after vaccination, huge study shows – Nature Original Study: Long COVID after breakthrough SARS-CoV-2 infection – Nature Medicine Commentary from the author on Twitter (thread – click for more) The latest from our team in @NatureMedicine Does vaccination protect from #LongCovid? Vaccines modestly reduce but do not […]
The post Study Commentary: Long COVID risk falls only slightly after vaccination, huge study shows. appeared first on Links Medicus.
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine Commentary on Twitter ?Just OutACTT-4 Trial?First Double Placebo-Controlled Double-Blind Randomized-Stratified Head-to-Head#DEXAMETHASONE vs #BARICITINIB for hospitalized pts w/#COVID19 Low/High-Flow/NIVRelevant?Patient Care/Public Health/GuidelinesOur results?https://t.co/4Tmue7HK7V ?1/4 pic.twitter.com/aF1Y7BAdu3 — Andre Kalil, MD MPH (@DrAndreKalil) May 24, 2022
The post RCT: Baricitinib vs. dexamethasone for adults hospitalized with COVID-19. appeared first on Links Medicus.
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin – Cochrane Library Summary: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs – Cochrane Library
The post Systematic Review: Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. appeared first on Links Medicus.
News Release: 20% of multi-drug resistant tuberculosis cases in children could be averted by household testing and treatment – London School of Hygiene & Tropical Medicine Original Study: The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study – The Lancet […]
The post Modeling Study: 20% of multi-drug resistant tuberculosis cases in children could be averted by household testing and treatment. appeared first on Links Medicus.